Joseph Group Capital Management

Position in PFE — Pfizer Inc

CIK 1910383 COLUMBUS, OH

Position in PFE

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$19,360

-$7,961 QoQ

Shares Held

804

-17.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#2,711

of 2,821 holders

Holding Since

Dec 2021

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Joseph Group Capital Management holds $11,807,916 across 9 Drug Manufacturers - General names. PFE ranks #8 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	5,241	$6,286,213
2	AMGN	Amgen Inc	14,086	$5,100,822
3	JNJ	Johnson & Johnson	589	$149,588
4	ABBV	AbbVie Inc.	421	$105,940
5	MRK	Merck & Co., Inc.	604	$77,614
6	GILD	Gilead Sciences, Inc.	327	$41,313
7	BMY	Bristol Myers Squibb Co	376	$21,665
8	PFE	Pfizer Inc This page	804	$19,360

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$19,360	804	-17.4%	Shares	Sole	2026-08-06
2026-03-31	$27,321	973	+286.1%	Shares	Sole	2026-05-08
2025-12-31	$6,274	252	-79.5%	Shares	Sole	2026-01-30
2024-09-30	$35,567	1,229	+168.3%	Shares	Sole	2024-11-07
2024-06-30	$12,814	458	-62.1%	Shares	Sole	2024-08-12
2024-03-31	$33,522	1,208	-58.7%	Shares	Sole	2024-05-13
2023-12-31	$84,297	2,928	-95.2%	Shares	Sole	2024-02-13
2023-09-30	$2,033,818	61,315	+31.8%	Shares	Sole	2023-11-13
2023-06-30	$1,705,876	46,507	+26.2%	Shares	Sole	2023-08-10
2023-03-31	$1,503,520	36,851	+18.4%	Shares	Sole	2023-05-04
2022-12-31	$1,594,845	31,125	-1.4%	Shares	Sole	2023-02-09
2022-09-30	$1,381,415	31,568	+6.4%	Shares	Sole	2022-11-09
2022-06-30	$1,555,178	29,662	+1.4%	Shares	Sole	2022-08-10
2022-03-31	$1,515,049	29,265	+2.4%	Shares	Sole	2022-05-11
2021-12-31	$1,686,822	28,566	—	Shares	Sole	2022-02-11
No filing history on record for this holder in this stock.